Table 1.
Mean ± SD | Patients, N (%) | |
---|---|---|
Age (years) | 36.6 ± 16.7 | |
BMI (kg/m2) | 18.7 ± 4.6 | |
Situs viscerum inversus | 22 (55%) | |
Chronic rhinosinusitis | 27 (67.5%) | |
Bronchiectasis | 29 (72.5%) | |
Colonization by P. aeruginosa | 15 (37.5%) | |
Bronchial asthma | 8 (20%) | |
Allergy | 10 (25%) | |
SARS-CoV-2 infection | 12 (30%) | |
Duration of symptoms (days) | 7.4 ± 4.5 | |
Severity of infection | ||
- Mild; | 10 (83.3%) | |
- Moderate; | 2 (16.7%) | |
- Severe. | 0 (0%) | |
Hospitalization | 0 (0%) | |
Vaccine doses | 3.5 ± 0.9 | |
FEV1 | 80.1 ± 17.3 | |
SNOT-22 | 28.7 ± 22.2 |